Duke ALS Clinic

Duke ALS Clinic multi-disciplinary team identifies specific ALS symptoms and problems and provides a wide range of options for dealing with them.

« All Events

  • This event has passed.

Dr. Bedlack’s views on a new Edaravone study were quoted on Medscape and ALZForum

January 17, 2022 All day

You can read it here:

https://www.medscape.com/viewarticle/966717#vp_1

https://www.alzforum.org/papers/safety-and-effectiveness-long-term-intravenous-administration-edaravone-treatment-patients#comment-43841